Rheuma Tolerance for Cure (RTCure) is a public-private partnership focusing on earlier detection and prevention of Rheumatoid Arthritis (RA). We wish to change the treatment paradigm from late and unspecific to early and specific. The overarching aim of our project is to prevent RA or its progression by inhibiting the expansion of pathogenic autoimmune responses through immune tolerising treatments. If successful, the type of therapy that RTCure is aiming for, may completely change today's management of RA worldwide, by inducing drug-free remission and removing the need for lifelong treatments in many patients.



  • Follow us on Twitter

Follow us on Twitter:

The RTCure project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement no 777357. This joint undertaking receives support from the European Union's Horizon 2020 Research and Innovation Programme and EFPIA.

The communication reflects the author's view; neither IMI nor the European Union or EFPIA  are responsible for any use that may be made of the information contained herein.